125 related articles for article (PubMed ID: 30129179)
1. GW0742 activates peroxisome proliferator-activated receptor δ to reduce free radicals and alleviate cardiac hypertrophy induced by hyperglycemia in cultured H9c2 cells.
Cheng KC; Chang WT; Li Y; Cheng YZ; Cheng JT; Chen ZC
J Cell Biochem; 2018 Nov; 119(11):9532-9542. PubMed ID: 30129179
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor-β/δ regulates angiogenic cell behaviors and oxygen-induced retinopathy.
Capozzi ME; McCollum GW; Savage SR; Penn JS
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4197-207. PubMed ID: 23716627
[TBL] [Abstract][Full Text] [Related]
3. Chronic peroxisome proliferator-activated receptorβ/δ agonist GW0742 prevents hypertension, vascular inflammatory and oxidative status, and endothelial dysfunction in diet-induced obesity.
Toral M; Gómez-Guzmán M; Jiménez R; Romero M; Zarzuelo MJ; Utrilla MP; Hermenegildo C; Cogolludo Á; Pérez-Vizcaíno F; Gálvez J; Duarte J
J Hypertens; 2015 Sep; 33(9):1831-44. PubMed ID: 26147382
[TBL] [Abstract][Full Text] [Related]
4. The PPARβ/δ agonist GW0742 modulates signaling pathways associated with cardiac myocyte growth via a non-genomic redox mechanism.
Galatou E; Kelly T; Lazou A
Mol Cell Biochem; 2014 Oct; 395(1-2):145-54. PubMed ID: 24939361
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-protein ligase E3a (UBE3A) as a new biomarker of cardiac hypertrophy in cell models.
Cheng KC; Li Y; Chang WT; Chen ZC; Cheng JT; Tsai CC
J Food Drug Anal; 2019 Jan; 27(1):355-364. PubMed ID: 30648591
[TBL] [Abstract][Full Text] [Related]
6. Cardiac peroxisome proliferator-activated receptor δ (PPARδ) as a new target for increased contractility without altering heart rate.
Chen ZC; Lee KS; Chen LJ; Wang LY; Niu HS; Cheng JT
PLoS One; 2013; 8(5):e64229. PubMed ID: 23724037
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.
Sheng L; Ye P; Liu YX; Han CG; Zhang ZY
Clin Exp Hypertens; 2008 Feb; 30(2):109-19. PubMed ID: 18293166
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms regarding potassium bromate‑induced cardiac hypertrophy without apoptosis in H9c2 cells.
Kuo SC; Li Y; Cheng YZ; Lee WJ; Cheng JT; Cheng KC
Mol Med Rep; 2018 Nov; 18(5):4700-4708. PubMed ID: 30221729
[TBL] [Abstract][Full Text] [Related]
9. Catalase Mediates the Inhibitory Actions of PPARδ against Angiotensin II-Triggered Hypertrophy in H9c2 Cardiomyocytes.
Hwang JS; Hur J; Lee WJ; Won JP; Lee HG; Lim DS; Kim E; Seo HG
Antioxidants (Basel); 2021 Jul; 10(8):. PubMed ID: 34439471
[TBL] [Abstract][Full Text] [Related]
10. A peroxisome proliferator-activated receptor-δ agonist provides neuroprotection in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Martin HL; Mounsey RB; Sathe K; Mustafa S; Nelson MC; Evans RM; Teismann P
Neuroscience; 2013 Jun; 240():191-203. PubMed ID: 23500098
[TBL] [Abstract][Full Text] [Related]
11. Protective role of peroxisome proliferator-activated receptor-β/δ against pulmonary oxygen toxicity mediated through changes in NOS expression levels.
Bao XC; Fang YQ; You P; Zhang S; Ma J
Exp Lung Res; 2014 Apr; 40(3):105-16. PubMed ID: 24624894
[TBL] [Abstract][Full Text] [Related]
12. Protective role of peroxisome proliferator-activated receptor-β/δ in septic shock.
Kapoor A; Shintani Y; Collino M; Osuchowski MF; Busch D; Patel NS; Sepodes B; Castiglia S; Fantozzi R; Bishop-Bailey D; Mota-Filipe H; Yaqoob MM; Suzuki K; Bahrami S; Desvergne B; Mitchell JA; Thiemermann C
Am J Respir Crit Care Med; 2010 Dec; 182(12):1506-15. PubMed ID: 20693380
[TBL] [Abstract][Full Text] [Related]
13. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
Coll T; Alvarez-Guardia D; Barroso E; Gómez-Foix AM; Palomer X; Laguna JC; Vázquez-Carrera M
Endocrinology; 2010 Apr; 151(4):1560-9. PubMed ID: 20185762
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor δ inhibits Porphyromonas gingivalis lipopolysaccharide-induced activation of matrix metalloproteinase-2 by downregulating NADPH oxidase 4 in human gingival fibroblasts.
Yoo T; Ham SA; Hwang JS; Lee WJ; Paek KS; Oh JW; Kim JH; Do JT; Han CW; Kim JH; Seo HG
Mol Oral Microbiol; 2016 Oct; 31(5):398-409. PubMed ID: 26403493
[TBL] [Abstract][Full Text] [Related]
15. The decreased expression of peroxisome proliferator-activated receptors delta (PPARdelta) is reversed by digoxin in the heart of diabetic rats.
Fan SC; Yu BC; Chen ZC; Chen LJ; Chung HH; Cheng JT
Horm Metab Res; 2010 Aug; 42(9):637-42. PubMed ID: 20446238
[TBL] [Abstract][Full Text] [Related]
16. Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats.
Yu BC; Chang CK; Ou HY; Cheng KC; Cheng JT
Cardiovasc Res; 2008 Oct; 80(1):78-87. PubMed ID: 18573863
[TBL] [Abstract][Full Text] [Related]
17. Carnitine palmitoyltransferase-1 up-regulation by PPAR-β/δ prevents lipid-induced endothelial dysfunction.
Toral M; Romero M; Jiménez R; Mahmoud AM; Barroso E; Gómez-Guzmán M; Sánchez M; Cogolludo Á; García-Redondo AB; Briones AM; Vázquez-Carrera M; Pérez-Vizcaíno F; Duarte J
Clin Sci (Lond); 2015 Nov; 129(9):823-37. PubMed ID: 26253087
[TBL] [Abstract][Full Text] [Related]
18. Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench.
Chang WT; Cheng JT; Chen ZC
Cardiovasc Diabetol; 2016 Aug; 15(1):113. PubMed ID: 27519769
[TBL] [Abstract][Full Text] [Related]
19. Vascular and Central Activation of Peroxisome Proliferator-Activated Receptor-β Attenuates Angiotensin II-Induced Hypertension: Role of RGS-5.
Romero M; Jiménez R; Toral M; León-Gómez E; Gómez-Gúzman M; Sánchez M; Zarzuelo MJ; Rodríguez-Gómez I; Rath G; Tamargo J; Pérez-Vizcaíno F; Dessy C; Duarte J
J Pharmacol Exp Ther; 2016 Jul; 358(1):151-63. PubMed ID: 27189971
[TBL] [Abstract][Full Text] [Related]
20. Effects of peroxisome proliferator-activated receptor-β activation in endothelin-dependent hypertension.
Zarzuelo MJ; Gómez-Guzmán M; Jiménez R; Quintela AM; Romero M; Sánchez M; Zarzuelo A; Tamargo J; Pérez-Vizcaíno F; Duarte J
Cardiovasc Res; 2013 Sep; 99(4):622-31. PubMed ID: 23752977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
